Labcorp Holdings Inc. Files 8-K

Ticker: LH · Form: 8-K · Filed: 2025-08-28T00:00:00.000Z

Sentiment: neutral

Topics: sec-filing, 8-k, disclosure

TL;DR

Labcorp filed an 8-K, likely containing financial updates.

AI Summary

On August 27, 2025, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This filing indicates that Labcorp Holdings Inc. is providing updates or disclosures to the SEC, which could contain important information for investors regarding the company's financial status or regulatory compliance.

Risk Assessment

Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain any specific material events or financial data that would indicate a change in risk.

Key Players & Entities

LABCORP HOLDINGS INC. (company) — Registrant
358 South Main Street (location) — Principal executive offices address
Burlington (location) — City of principal executive offices
North Carolina (location) — State of principal executive offices
27215 (location) — Zip code of principal executive offices
336 - 229-1127 (phone_number) — Registrant's telephone number

FAQ

What is the primary purpose of this 8-K filing?

The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.

What is the exact name of the company filing this report?

The exact name of the registrant is LABCORP HOLDINGS INC.

On what date was the earliest event reported in this filing?

The earliest event reported was on August 27, 2025.

Where are LABCORP HOLDINGS INC.'s principal executive offices located?

The principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.

What is the Commission File Number for LABCORP HOLDINGS INC.?

The Commission File Number is 1-11353.

From the Filing

0000920148-25-000085.txt : 20250828 0000920148-25-000085.hdr.sgml : 20250828 20250828161019 ACCESSION NUMBER: 0000920148-25-000085 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250827 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250828 DATE AS OF CHANGE: 20250828 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 251273494 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 lh-20250827.htm 8-K lh-20250827 0000920148 false 0000920148 2025-08-27 2025-08-27 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 27, 2025 (Date of earliest event reported) LABCORP HOLDINGS INC. (Exact Name of Registrant as Specified in its Charter) Delaware   1-11353   99-2588107 (State or other jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.) 358 South Main Street   Burlington , North Carolina 27215 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number including area code) 336 - 229-1127 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of exchange on which registered Common Stock, $0.10 par value LH New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).              Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01 Regulation FD Disclosure Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on August 27, 2025 that members of the executive management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, at 7:45 am ET. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein. A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay. Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated August 27 , 2025 issued by Labcor